Bitget App
Mag-trade nang mas matalino
Buy cryptoMarketsTradeFuturesEarnSquareMore

RNAC stock price forecast

How will RNAC stock perform in 2026 and 2030?

This page primarily displays the projected price range for RNAC stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of RNAC, the development trends of Cartesian Therapeutics, Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for RNAC. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Cartesian Therapeutics, Inc.'s financial performance and industry trends to provide short-term price predictions for RNAC stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year RNAC stock price forecast

Price target:
13.72 USD
+110.43%
Based on 1-year price forecasts from 31 analysts, the highest estimate is 19.25 USD, while the lowest estimate is 7.14 USD.

Analyst rating for RNAC

Based on ratings from 22 analysts over the past three months, the overall consensus is Hold.

Strong buy
1
Buy
11
Hold
4
Sell
1
Strong sell
5

FAQ

How has RNAC's EPS performed recently?

RNAC's EPS is projected to reach -- USD next quarter. Explore more Cartesian Therapeutics, Inc. financial data and stay up to date on the company's latest developments on the RNAC stock details page.

What is the revenue forecast for RNAC next quarter?

Cartesian Therapeutics, Inc.'s revenue is projected to reach 150.33K USD USD in the next quarter. You can view Cartesian Therapeutics, Inc.'s revenue and earnings on the RNAC stock details page.

What is the price target for RNAC?

Based on analyst estimates, the most likely target price for RNAC over the next 12 months is 13.72 USD, with a projected high of 19.25 USD and a projected low of 7.14 USD. To track whether this target is reached within the next year, you can view the RNAC stock price chart on the RNAC stock details page to check the current RNAC stock price, or follow the latest developments related to RNAC on the RNAC Stock News page.

What is the analyst rating for RNAC?

We collected ratings from 22 analysts who have evaluated RNAC stock over the past three months. Most analysts maintain a Hold outlook, and after aggregating all opinions, the overall consensus rating is Hold. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of RNAC stock in 2030?

Based on price forecasts and analyses of Cartesian Therapeutics, Inc. from Wall Street analysts and major investment banks, RNAC is projected to trade between 13.04 USD and 65.20 USD in 2030.

RNAC stock chart

RNAC stock details

RNAC stock price change

Sa huling araw ng trading, RNAC sarado ang stock sa 6.52 USD, na may pagbabago sa presyo ng 1.72% para sa araw.

Trade stock futures

Tungkol kay Bitget

Ang unang Universal Exchange (UEX) sa mundo, na nagbibigay-daan sa mga gumagamit na mag-trade hindi lamang ng mga cryptocurrency, kundi pati na rin ng mga stock, ETF, forex, gold, at mga real-world asset (RWA).
Learn more
NASDAQ/
RNAC stock price forecast